Gene · 3906
Papers3,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Milk: A Natural Guardian for the Gut Barrier. | J Agric Food Chem | 2024 | 38588092 | PubTator, text mining | PubMed |
| The Shelf Life of Milk-A Novel Concept for the Identification of Marker Peptides Using Multivariate Analysis. | Foods | 2024 | 38540821 | PubTator, text mining | PubMed |
| Effects of lactalbumin enzymatic hydrolysate on human squamous cell carcinoma cells-an in vitro study. | J Oral Biol Craniofac Res | 2024 | 38495954 | PubTator, text mining | PubMed |
| The affinity of milk fat globule membrane fragments and buttermilk proteins to hydroxyapatite. | J Dairy Sci | 2024 | 38490551 | PubTator, text mining | PubMed |
| "Milk on Ice": A detailed analysis of Ernest Shackleton's century-old whole milk powder in comparison with modern counterparts. | J Dairy Sci | 2024 | 38423728 | PubTator, text mining | PubMed |
| Production, Composition and Nutritional Properties of Organic Milk: A Critical Review. | Foods | 2024 | 38397527 | PubTator, text mining | PubMed |
| Modulation of the electrostatic potential around α-lactalbumin using oligoelectrolyte chains, pH and salt concentration. | Soft Matter | 2024 | 38348915 | PubTator, text mining | PubMed |
| Wheat gliadin hydrolysates based nano-micelles for hydrophobic naringin: Structure characterization, interaction, and in vivo digestion. | Food Chem X | 2024 | 38298357 | PubTator, text mining | PubMed |
| Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview. | Front Immunol | 2024 | 38298192 | PubTator, text mining | PubMed |
| Ionic regulation whey protein composition on membrane fouling during ultrafiltration process analyzed by HPLC. | Int J Biol Macromol | 2024 | 38287593 | PubTator, text mining | PubMed |
| Whey proteins as multifunctional food materials: Recent advancements in hydrolysis, separation, and peptidomimetic approaches. | Compr Rev Food Sci Food Saf | 2024 | 38284584 | PubTator, text mining | PubMed |
| Characterizations of emulsion gel formed with the mixture of whey and soy protein and its protein digestion under in vitro gastric conditions. | Curr Res Food Sci | 2024 | 38283161 | PubTator, text mining | PubMed |
| Bovine Serum Albumin Rejection by an Open Ultrafiltration Membrane: Characterization and Modeling. | Membranes (Basel) | 2024 | 38276317 | PubTator, text mining | PubMed |
| Label-free-based proteomic analysis reveals differential whey proteins of porcine milk during lactation. | Food Chem X | 2024 | 38268845 | PubTator, text mining | PubMed |
| Assessing the Therapeutic Impacts of HAMLET and FOLFOX on BRAF-Mutated Colorectal Cancer: A Study of Cancer Cell Survival and Mitochondrial Dynamics In Vitro and Ex Vivo. | Medicina (Kaunas) | 2024 | 38256402 | PubTator, text mining | PubMed |
| Investigating the Health Implications of Whey Protein Consumption: A Narrative Review of Risks, Adverse Effects, and Associated Health Issues. | Healthcare (Basel) | 2024 | 38255133 | PubTator, text mining | PubMed |
| Systemic and Local Strategies for Primary Prevention of Breast Cancer. | Cancers (Basel) | 2024 | 38254741 | PubTator, text mining | PubMed |
| Recent Advances in Metalloproteomics. | Biomolecules | 2024 | 38254704 | PubTator, text mining | PubMed |
| Circadian Rhythms, Chrononutrition, Physical Training, and Redox Homeostasis-Molecular Mechanisms in Human Health. | Cells | 2024 | 38247830 | PubTator, text mining | PubMed |
| Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future. | Expert Opin Drug Metab Toxicol | 2024 | 38226638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3906/papers?page=11